tiprankstipranks
Trending News
More News >
Blum Holdings Inc (BLMH)
:BLMH

Blum Holdings (BLMH) AI Stock Analysis

Compare
722 Followers

Top Page

BL

Blum Holdings

(OTC:BLMH)

50Neutral
Blum Holdings' overall stock score reflects a blend of significant financial instability and potential recovery prospects. The company's financial performance remains a primary concern with unstable revenue and high leverage. However, recent corporate events, including settlements and strategic restructuring, present a positive outlook for future stabilization. Valuation metrics suggest possible undervaluation, but the technical indicators remain mixed, offering no strong directional trend.

Blum Holdings (BLMH) vs. S&P 500 (SPY)

Blum Holdings Business Overview & Revenue Model

Company DescriptionBlum Holdings, Inc. cultivates, manufactures, distributes, and retails medical and adult use cannabis products in California. The company operates through Cannabis Retail and Cannabis Distribution segments. It also manages medical marijuana retail and adult use dispensaries, cultivation, and manufacturing facilities. The company was formerly known as Unrivaled Brands, Inc. and changed its name to Blum Holdings, Inc. in January 2024. Blum Holdings, Inc. was founded in 2010 and is headquartered in Santa Ana, California.
How the Company Makes MoneyBlum Holdings generates revenue through a diversified portfolio of business units. In the technology sector, it earns money by developing and licensing software solutions to enterprise clients, which include proprietary platforms and cloud-based services. In healthcare, the company makes money through the sale and distribution of medical devices, often facilitated by partnerships with hospitals and healthcare providers. Additionally, Blum Holdings capitalizes on the growing demand for renewable energy by manufacturing and installing solar panels and energy storage systems, often working in collaboration with government bodies and private enterprises to deploy large-scale solar projects. Key factors contributing to its earnings include strategic partnerships, a strong focus on research and development, and a commitment to sustainability that aligns with global environmental initiatives.

Blum Holdings Financial Statement Overview

Summary
Blum Holdings faces significant financial challenges. Revenue volatility, negative stockholders' equity, and cash flow issues highlight financial instability. Improvements in gross profit margin and a one-time net income boost in 2024 offer some optimism, but the overall financial position remains weak.
Income Statement
Blum Holdings has experienced significant fluctuations in revenue and profitability. The company shows a drastic decrease in revenue from $52 million in 2022 to $13 million in 2024. The gross profit margin has improved in the latest year, but net income remains negative except for a one-time large net income in 2024. EBIT margins have improved but are inconsistent, indicating operational challenges. Overall, the income statement reflects unstable revenue and profitability trends.
Balance Sheet
30
The company's balance sheet highlights significant financial distress, with negative stockholders' equity of $4.7 million in 2024, indicating more liabilities than assets. The debt-to-equity ratio cannot be calculated due to negative equity, which is a major risk factor. The equity ratio is negative, and return on equity is not meaningful due to negative equity. The balance sheet reflects high leverage and potential insolvency risks.
Cash Flow
Blum Holdings displays negative operating cash flow and free cash flow, indicating cash flow issues. The operating cash flow to net income ratio is negative, and free cash flow has not shown consistent improvement. The company’s cash flow position suggests ongoing liquidity challenges.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
12.99M33.23M52.02M42.12M6.16M
Gross Profit
6.21M14.00M16.90M11.02M2.64M
EBIT
5.38M-12.60M-193.76M-38.33M-36.59M
EBITDA
5.38M-2.26M-171.57M-30.07M-1.83M
Net Income Common Stockholders
33.10M-14.13M-188.93M-31.27M-30.12M
Balance SheetCash, Cash Equivalents and Short-Term Investments
1.04M862.00K1.20M6.70M34.26M
Total Assets
24.82M32.07M40.51M271.82M100.29M
Total Debt
4.79M37.70M49.56M79.41M23.13M
Net Debt
3.75M36.84M48.36M72.71M22.92M
Total Liabilities
29.56M77.77M77.05M125.34M41.16M
Stockholders Equity
-4.74M-45.70M-36.54M142.63M54.67M
Cash FlowFree Cash Flow
-2.15M-1.29M-9.76M-21.93M-16.31M
Operating Cash Flow
-2.14M-965.00K-7.83M-17.96M-14.84M
Investing Cash Flow
2.03M462.00K19.61M21.67M11.80M
Financing Cash Flow
143.00K539.00K-17.27M4.50M2.70M

Blum Holdings Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.83
Price Trends
50DMA
0.83
Positive
100DMA
0.83
Positive
200DMA
0.62
Positive
Market Momentum
MACD
-0.02
Positive
RSI
52.50
Neutral
STOCH
39.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BLMH, the sentiment is Positive. The current price of 0.83 is above the 20-day moving average (MA) of 0.77, above the 50-day MA of 0.83, and above the 200-day MA of 0.62, indicating a bullish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 52.50 is Neutral, neither overbought nor oversold. The STOCH value of 39.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BLMH.

Blum Holdings Risk Analysis

Blum Holdings disclosed 56 risk factors in its most recent earnings report. Blum Holdings reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Blum Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
52
Neutral
$5.17B3.59-42.19%2.82%15.05%-0.04%
50
Neutral
$11.25M0.74-27.37%-44.99%
48
Neutral
$13.36M-96.89%175.03%55.34%
43
Neutral
$11.08M-291.50%-22.58%82.94%
40
Underperform
$10.02M-64.18%1.00%
36
Underperform
$13.36M-499.57%22.15%
34
Underperform
$11.26M8.47>-0.01%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BLMH
Blum Holdings
0.83
0.12
16.90%
NERV
Minerva Neurosciences
1.61
-0.83
-34.02%
PAVM
PAVmed
0.68
-1.24
-64.58%
BRTX
BioRestorative Therapies
1.80
0.49
37.40%
SNSE
Sensei Biotherapeutics
0.36
-1.21
-77.07%
FLGC
Flora Growth
0.68
-0.67
-49.63%

Blum Holdings Corporate Events

Private Placements and Financing
Blum Holdings Executes $1M Unsecured Promissory Note
Neutral
May 7, 2025

On May 2, 2025, Blum Holdings, Inc. executed an Unsecured Promissory Note worth $1,000,000 with a maturity date of May 2, 2027, and an interest rate of 8% per annum. This financial move allows the lender to convert the note into shares at a discounted rate and includes warrants for purchasing additional shares, potentially impacting Blum’s capital structure and investor relations.

Spark’s Take on BLMH Stock

According to Spark, TipRanks’ AI Analyst, BLMH is a Neutral.

Blum Holdings presents a mixed picture. Significant financial instability, as reflected in negative earnings and cash flow challenges, weighs heavily on the stock. However, recent positive corporate events and a low P/E ratio offer some optimism for recovery. Technical indicators are mixed, reflecting uncertainty. The company’s future performance heavily depends on effective execution of its restructuring and strategic initiatives.

To see Spark’s full report on BLMH stock, click here.

Legal ProceedingsBusiness Operations and Strategy
Blum Holdings Announces Settlement with People’s California
Positive
Apr 14, 2025

On April 14, 2025, Blüm Holdings announced a significant update regarding its settlement with People’s California, LLC, originally reported on February 24, 2025. The settlement, which requires court approval, aims to resolve all outstanding litigation and adversary proceedings involving the company and its subsidiaries, Unrivaled Brands, Inc. and Halladay Holding, LLC, which are currently in Chapter 11 bankruptcy. If approved, this settlement is expected to be a major milestone in Blüm’s restructuring efforts, potentially providing greater clarity and stability for stakeholders.

Spark’s Take on BLMH Stock

According to Spark, TipRanks’ AI Analyst, BLMH is a Neutral.

Blum Holdings’ stock score reflects a mix of financial instability and potential recovery. Significant financial challenges weigh heavily, but recent corporate events and a low P/E ratio provide optimism. Technical indicators are mixed, showing neither strong bullish nor bearish trends. The company’s future performance hinges on executing its strategic initiatives successfully.

To see Spark’s full report on BLMH stock, click here.

M&A TransactionsBusiness Operations and StrategyFinancial Disclosures
Blum Holdings Reports Major Financial Turnaround in 2024
Positive
Mar 13, 2025

Blum Holdings, a California-based cannabis operator, reported a significant financial turnaround for the year ended December 31, 2024, with a net income of $33.1 million, marking a stark improvement from previous losses. The company’s restructuring efforts, including the strategic divestment of non-core dispensaries and integration of key retail locations, resulted in a 67% revenue increase and a 62% reduction in liabilities. This transformation has positioned Blum Holdings for future growth, as it transitions from restructuring to expansion, focusing on strategic acquisitions and market presence enhancement.

Legal ProceedingsBusiness Operations and Strategy
Blüm Holdings Reaches Global Settlement with People’s California
Positive
Feb 24, 2025

On February 24, 2025, Blüm Holdings, a California-based cannabis operator, announced a global settlement with People’s California, LLC, resolving over two and a half years of litigation. The settlement, which includes mutual releases and the dismissal of several lawsuits, is expected to support the Debtors’ Chapter 11 plan and has been verbally ratified by the involved parties. This resolution marks a significant step for Blüm Holdings, potentially stabilizing its operations and enhancing its industry positioning.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.